UnitedHealth Pretax Profit Margin from 2010 to 2024

UNH Stock  USD 491.23  9.90  1.98%   
UnitedHealth Group's Pretax Profit Margin is increasing with stable movements from year to year. Pretax Profit Margin is predicted to flatten to 0.06. For the period between 2010 and 2024, UnitedHealth Group, Pretax Profit Margin quarterly trend regression had mean deviation of  0.01 and range of 0.0413. View All Fundamentals
 
Pretax Profit Margin  
First Reported
2010-12-31
Previous Quarter
0.07833767
Current Value
0.0562
Quarterly Volatility
0.01090092
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check UnitedHealth Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among UnitedHealth main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 B, Total Revenue of 390.2 B or Gross Profit of 95.5 B, as well as many exotic indicators such as Price To Sales Ratio of 1.17, Dividend Yield of 0.0145 or PTB Ratio of 3.18. UnitedHealth financial statements analysis is a perfect complement when working with UnitedHealth Group Valuation or Volatility modules.
  
This module can also supplement UnitedHealth Group's financial leverage analysis and stock options assessment as well as various UnitedHealth Group Technical models . Check out the analysis of UnitedHealth Group Correlation against competitors.

Latest UnitedHealth Group's Pretax Profit Margin Growth Pattern

Below is the plot of the Pretax Profit Margin of UnitedHealth Group Incorporated over the last few years. It is UnitedHealth Group's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in UnitedHealth Group's overall financial position and show how it may be relating to other accounts over time.
Pretax Profit Margin10 Years Trend
Pretty Stable
   Pretax Profit Margin   
       Timeline  

UnitedHealth Pretax Profit Margin Regression Statistics

Arithmetic Mean0.07
Geometric Mean0.07
Coefficient Of Variation15.31
Mean Deviation0.01
Median0.07
Standard Deviation0.01
Sample Variance0.0001
Range0.0413
R-Value0.28
Mean Square Error0.0001
R-Squared0.08
Significance0.31
Slope0.0007
Total Sum of Squares0

UnitedHealth Pretax Profit Margin History

2024 0.0562
2023 0.0783
2022 0.0818
2021 0.0782
2020 0.0811
2019 0.0748
2018 0.0709

About UnitedHealth Group Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include UnitedHealth Group income statement, its balance sheet, and the statement of cash flows. UnitedHealth Group investors use historical funamental indicators, such as UnitedHealth Group's Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Although UnitedHealth Group investors may use each financial statement separately, they are all related. The changes in UnitedHealth Group's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on UnitedHealth Group's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on UnitedHealth Group Financial Statements. Understanding these patterns can help to make the right decision on long term investment in UnitedHealth Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.08  0.06 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:
Check out the analysis of UnitedHealth Group Correlation against competitors.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for UnitedHealth Stock analysis

When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is UnitedHealth Group's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.16
Dividend Share
7.52
Earnings Share
16.39
Revenue Per Share
411.257
Quarterly Revenue Growth
0.086
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.